An Azidoribose Probe to Track Ketoamine Adducts in Histone Ribose Glycation
Overview
Affiliations
Reactive cellular metabolites can modify macromolecules and form adducts known as nonenzymatic covalent modifications (NECMs). The dissection of the mechanisms, regulation, and consequences of NECMs, such as glycation, has been challenging due to the complex and often ambiguous nature of the adducts formed. Specific chemical tools are required to directly track the formation of these modifications on key targets in order to uncover their underlying physiological importance. Here, we present the novel chemoenzymatic synthesis of an active azido-modified ribose analog, 5-azidoribose (), as well as the synthesis of an inactive control derivative, 1-azidoribose (), and their application toward understanding protein ribose-glycation and . With these new probes we found that, similar to methylglyoxal (MGO) glycation, ribose glycation specifically accumulates on histones. In addition to fluorescent labeling, we demonstrate the utility of the probe in enriching modified targets, which were identified by label-free quantitative proteomics and high-resolution MS/MS workflows. Finally, we establish that the known oncoprotein and hexose deglycase, fructosamine 3-kinase (FN3K), recognizes and facilitates the removal of glycation adducts in live cells, supporting the dynamic regulation of ribose glycation as well as validating the probe as a new platform to monitor FN3K activity. Altogether, we demonstrate this probe's utilities to uncover ribose-glycation and deglycation events as well as track FN3K activity toward establishing its potential as a new cancer vulnerability.
Structural basis for FN3K-mediated protein deglycation.
Lokhandwala J, Matlack J, Smalley T, Miner 3rd R, Tran T, Binning J Structure. 2024; 32(10):1711-1724.e5.
PMID: 39173621 PMC: 11455621. DOI: 10.1016/j.str.2024.07.018.
The chemical language of protein glycation.
Martin M, Jacob-Dolan J, Pham V, Sjoblom N, Scheck R Nat Chem Biol. 2024; 21(3):324-336.
PMID: 38942948 DOI: 10.1038/s41589-024-01644-y.
Epigenetic meets metabolism: novel vulnerabilities to fight cancer.
Scumaci D, Zheng Q Cell Commun Signal. 2023; 21(1):249.
PMID: 37735413 PMC: 10512595. DOI: 10.1186/s12964-023-01253-7.
A global view of the human post-translational modification landscape.
Kitamura N, Galligan J Biochem J. 2023; 480(16):1241-1265.
PMID: 37610048 PMC: 10586784. DOI: 10.1042/BCJ20220251.
Reconsidering the role of protein glycation in disease.
Trujillo M, Galligan J Nat Chem Biol. 2023; 19(8):922-927.
PMID: 37430113 PMC: 10807257. DOI: 10.1038/s41589-023-01382-7.